MiraDx Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
2ndary - Private
MiraDx General Information
Description
Developer of pharmacogenomics tests for radiation therapy designed to improve the assessment of individual cancer risk. The company's pharmacogenomics tests personalize cancer treatment and provide women with information about the risk of ovarian and breast cancer that they face, enabling hospitals to prevent and cure cancer in women.
Contact Information
Website
www.miradx.comCorporate Office
- 11600 Wilshire Boulevard
- Suite 2410
- Los Angeles, CA 90025
- United States
Corporate Office
- 11600 Wilshire Boulevard
- Suite 2410
- Los Angeles, CA 90025
- United States
MiraDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Apr-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 23-Aug-2010 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2009 | Completed | Generating Revenue |
MiraDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
MiraDx Patents
MiraDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4103277-A1 | Biomarkers for predicting toxicity of radiation | Pending | 12-Feb-2020 | ||
| EP-4103277-A4 | Biomarkers for predicting toxicity of radiation | Pending | 12-Feb-2020 | ||
| US-20230103419-A1 | Biomarkers for predicting toxicity of radiation | Pending | 12-Feb-2020 | ||
| WO-2021163609-A1 | Biomarkers for predicting toxicity of radiation | Inactive | 12-Feb-2020 | ||
| AU-2018283314-A1 | Biomarkers for predicting tumor response to and toxicity of immunotherapy | Active | 15-Jun-2017 | C12Q1/6886 |
MiraDx Signals
MiraDx FAQs
-
When was MiraDx founded?
MiraDx was founded in 2008.
-
Where is MiraDx headquartered?
MiraDx is headquartered in Los Angeles, CA.
-
What is the size of MiraDx?
MiraDx has 19 total employees.
-
What industry is MiraDx in?
MiraDx’s primary industry is Biotechnology.
-
Is MiraDx a private or public company?
MiraDx is a Private company.
-
What is MiraDx’s current revenue?
The current revenue for MiraDx is .
-
How much funding has MiraDx raised over time?
MiraDx has raised $4.16M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process